Increased peritoneal damage in glyoxalase 1 knock-down mice treated with peritoneal dialysis

Lars P. Kihm, Sandra Müller-Krebs, Sandra Holoch, Svenja Schmuck, Luis E. Becker, Michael Brownlee, Martin Zeier, Thomas H. Fleming, Peter P. Nawroth, Vedat Schwenger

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background Peritoneal dialysis (PD) is limited by peritoneal fibrosis and ultrafiltration failure. This is in part caused by the high concentration of glucose degradation products (GDPs) present in PD fluids (PDF) as a consequence of heat sterilization. Existing research in long-term PD has mainly dealt with the toxicity induced by GDPs and the development of therapeutic strategies to reduce the cellular burden of GDPs. Currently, there are few data regarding the potential role of detoxification systems of GDP in PD. In this study, the role of glyoxalase 1 (Glo1), the major detoxification pathway for dicarbonyl-derived GD such as methylglyoxal (MG) and glyoxal (Gx), was investigated in vivo using heterozygous knock-down mice for Glo1 (Glo1 '/+). Methods Wild-type (WT) and Glo1 '/+ mice were repeatedly treated with PDF containing low and high amounts of GDP, particularly with respect to the content of dicarbonyls. After 12 weeks of treatment with PDF, peritoneal damage and function were evaluated. Results Glo1 '/+ mice treated with PDF showed increased formation of advanced glycation endproduct (AGE) when compared with WT mice, particularly the Gx-derived AGE, carboxymethyl-lysine. This was associated with increased inflammation, neovascularization, increased peritoneal fibrosis and impaired peritoneal function. Conclusions This study suggests a pivotal and underestimated role for Glo1 as a detoxifying enzyme in GDP-associated peritoneal toxicity in PD. The indirect and direct modulation of Glo1 may therefore offer a new therapeutic option in prevention of GDP-induced peritoneal damage in PD.

Original languageEnglish (US)
Pages (from-to)401-409
Number of pages9
JournalNephrology Dialysis Transplantation
Volume30
Issue number3
DOIs
StatePublished - Mar 1 2015

Fingerprint

Peritoneal Dialysis
Glucose
Peritoneal Fibrosis
Glyoxal
Ascitic Fluid
Pyruvaldehyde
Ultrafiltration
Therapeutics
Hot Temperature
Inflammation
Enzymes
Research

Keywords

  • glucose degradation products
  • glyoxalase
  • methylglyoxal
  • mice
  • peritoneal dialysis

ASJC Scopus subject areas

  • Nephrology
  • Transplantation

Cite this

Kihm, L. P., Müller-Krebs, S., Holoch, S., Schmuck, S., Becker, L. E., Brownlee, M., ... Schwenger, V. (2015). Increased peritoneal damage in glyoxalase 1 knock-down mice treated with peritoneal dialysis. Nephrology Dialysis Transplantation, 30(3), 401-409. https://doi.org/10.1093/ndt/gfu346

Increased peritoneal damage in glyoxalase 1 knock-down mice treated with peritoneal dialysis. / Kihm, Lars P.; Müller-Krebs, Sandra; Holoch, Sandra; Schmuck, Svenja; Becker, Luis E.; Brownlee, Michael; Zeier, Martin; Fleming, Thomas H.; Nawroth, Peter P.; Schwenger, Vedat.

In: Nephrology Dialysis Transplantation, Vol. 30, No. 3, 01.03.2015, p. 401-409.

Research output: Contribution to journalArticle

Kihm, LP, Müller-Krebs, S, Holoch, S, Schmuck, S, Becker, LE, Brownlee, M, Zeier, M, Fleming, TH, Nawroth, PP & Schwenger, V 2015, 'Increased peritoneal damage in glyoxalase 1 knock-down mice treated with peritoneal dialysis', Nephrology Dialysis Transplantation, vol. 30, no. 3, pp. 401-409. https://doi.org/10.1093/ndt/gfu346
Kihm, Lars P. ; Müller-Krebs, Sandra ; Holoch, Sandra ; Schmuck, Svenja ; Becker, Luis E. ; Brownlee, Michael ; Zeier, Martin ; Fleming, Thomas H. ; Nawroth, Peter P. ; Schwenger, Vedat. / Increased peritoneal damage in glyoxalase 1 knock-down mice treated with peritoneal dialysis. In: Nephrology Dialysis Transplantation. 2015 ; Vol. 30, No. 3. pp. 401-409.
@article{50e8d7bacf564f1eb1cb03bff08a29bd,
title = "Increased peritoneal damage in glyoxalase 1 knock-down mice treated with peritoneal dialysis",
abstract = "Background Peritoneal dialysis (PD) is limited by peritoneal fibrosis and ultrafiltration failure. This is in part caused by the high concentration of glucose degradation products (GDPs) present in PD fluids (PDF) as a consequence of heat sterilization. Existing research in long-term PD has mainly dealt with the toxicity induced by GDPs and the development of therapeutic strategies to reduce the cellular burden of GDPs. Currently, there are few data regarding the potential role of detoxification systems of GDP in PD. In this study, the role of glyoxalase 1 (Glo1), the major detoxification pathway for dicarbonyl-derived GD such as methylglyoxal (MG) and glyoxal (Gx), was investigated in vivo using heterozygous knock-down mice for Glo1 (Glo1 '/+). Methods Wild-type (WT) and Glo1 '/+ mice were repeatedly treated with PDF containing low and high amounts of GDP, particularly with respect to the content of dicarbonyls. After 12 weeks of treatment with PDF, peritoneal damage and function were evaluated. Results Glo1 '/+ mice treated with PDF showed increased formation of advanced glycation endproduct (AGE) when compared with WT mice, particularly the Gx-derived AGE, carboxymethyl-lysine. This was associated with increased inflammation, neovascularization, increased peritoneal fibrosis and impaired peritoneal function. Conclusions This study suggests a pivotal and underestimated role for Glo1 as a detoxifying enzyme in GDP-associated peritoneal toxicity in PD. The indirect and direct modulation of Glo1 may therefore offer a new therapeutic option in prevention of GDP-induced peritoneal damage in PD.",
keywords = "glucose degradation products, glyoxalase, methylglyoxal, mice, peritoneal dialysis",
author = "Kihm, {Lars P.} and Sandra M{\"u}ller-Krebs and Sandra Holoch and Svenja Schmuck and Becker, {Luis E.} and Michael Brownlee and Martin Zeier and Fleming, {Thomas H.} and Nawroth, {Peter P.} and Vedat Schwenger",
year = "2015",
month = "3",
day = "1",
doi = "10.1093/ndt/gfu346",
language = "English (US)",
volume = "30",
pages = "401--409",
journal = "Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association",
issn = "0931-0509",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Increased peritoneal damage in glyoxalase 1 knock-down mice treated with peritoneal dialysis

AU - Kihm, Lars P.

AU - Müller-Krebs, Sandra

AU - Holoch, Sandra

AU - Schmuck, Svenja

AU - Becker, Luis E.

AU - Brownlee, Michael

AU - Zeier, Martin

AU - Fleming, Thomas H.

AU - Nawroth, Peter P.

AU - Schwenger, Vedat

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Background Peritoneal dialysis (PD) is limited by peritoneal fibrosis and ultrafiltration failure. This is in part caused by the high concentration of glucose degradation products (GDPs) present in PD fluids (PDF) as a consequence of heat sterilization. Existing research in long-term PD has mainly dealt with the toxicity induced by GDPs and the development of therapeutic strategies to reduce the cellular burden of GDPs. Currently, there are few data regarding the potential role of detoxification systems of GDP in PD. In this study, the role of glyoxalase 1 (Glo1), the major detoxification pathway for dicarbonyl-derived GD such as methylglyoxal (MG) and glyoxal (Gx), was investigated in vivo using heterozygous knock-down mice for Glo1 (Glo1 '/+). Methods Wild-type (WT) and Glo1 '/+ mice were repeatedly treated with PDF containing low and high amounts of GDP, particularly with respect to the content of dicarbonyls. After 12 weeks of treatment with PDF, peritoneal damage and function were evaluated. Results Glo1 '/+ mice treated with PDF showed increased formation of advanced glycation endproduct (AGE) when compared with WT mice, particularly the Gx-derived AGE, carboxymethyl-lysine. This was associated with increased inflammation, neovascularization, increased peritoneal fibrosis and impaired peritoneal function. Conclusions This study suggests a pivotal and underestimated role for Glo1 as a detoxifying enzyme in GDP-associated peritoneal toxicity in PD. The indirect and direct modulation of Glo1 may therefore offer a new therapeutic option in prevention of GDP-induced peritoneal damage in PD.

AB - Background Peritoneal dialysis (PD) is limited by peritoneal fibrosis and ultrafiltration failure. This is in part caused by the high concentration of glucose degradation products (GDPs) present in PD fluids (PDF) as a consequence of heat sterilization. Existing research in long-term PD has mainly dealt with the toxicity induced by GDPs and the development of therapeutic strategies to reduce the cellular burden of GDPs. Currently, there are few data regarding the potential role of detoxification systems of GDP in PD. In this study, the role of glyoxalase 1 (Glo1), the major detoxification pathway for dicarbonyl-derived GD such as methylglyoxal (MG) and glyoxal (Gx), was investigated in vivo using heterozygous knock-down mice for Glo1 (Glo1 '/+). Methods Wild-type (WT) and Glo1 '/+ mice were repeatedly treated with PDF containing low and high amounts of GDP, particularly with respect to the content of dicarbonyls. After 12 weeks of treatment with PDF, peritoneal damage and function were evaluated. Results Glo1 '/+ mice treated with PDF showed increased formation of advanced glycation endproduct (AGE) when compared with WT mice, particularly the Gx-derived AGE, carboxymethyl-lysine. This was associated with increased inflammation, neovascularization, increased peritoneal fibrosis and impaired peritoneal function. Conclusions This study suggests a pivotal and underestimated role for Glo1 as a detoxifying enzyme in GDP-associated peritoneal toxicity in PD. The indirect and direct modulation of Glo1 may therefore offer a new therapeutic option in prevention of GDP-induced peritoneal damage in PD.

KW - glucose degradation products

KW - glyoxalase

KW - methylglyoxal

KW - mice

KW - peritoneal dialysis

UR - http://www.scopus.com/inward/record.url?scp=84924405588&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924405588&partnerID=8YFLogxK

U2 - 10.1093/ndt/gfu346

DO - 10.1093/ndt/gfu346

M3 - Article

VL - 30

SP - 401

EP - 409

JO - Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

JF - Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

SN - 0931-0509

IS - 3

ER -